These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
167 related articles for article (PubMed ID: 15170665)
1. Pretreatment evaluation of combined HIF-1alpha, p53 and p21 expression is a useful and sensitive indicator of response to radiation and chemotherapy in esophageal cancer. Sohda M; Ishikawa H; Masuda N; Kato H; Miyazaki T; Nakajima M; Fukuchi M; Manda R; Fukai Y; Sakurai H; Kuwano H Int J Cancer; 2004 Jul; 110(6):838-44. PubMed ID: 15170665 [TBL] [Abstract][Full Text] [Related]
2. Expression of p53 protein in esophageal squamous cell carcinoma: relation to hypoxia-inducible factor-1alpha, angiogenesis and apoptosis. Kimura S; Kitadai Y; Kuwai T; Tanaka S; Hihara J; Yoshida K; Toge T; Chayama K Pathobiology; 2005; 72(4):179-85. PubMed ID: 16127293 [TBL] [Abstract][Full Text] [Related]
3. Clinical significance of HIF-1alpha expression in patients with esophageal cancer treated with concurrent chemoradiotherapy. Ogawa K; Chiba I; Morioka T; Shimoji H; Tamaki W; Takamatsu R; Nishimaki T; Yoshimi N; Murayama S Anticancer Res; 2011 Jun; 31(6):2351-9. PubMed ID: 21737664 [TBL] [Abstract][Full Text] [Related]
4. Expression of hypoxia-inducible factor-1alpha and cell cycle proteins in invasive breast cancer are estrogen receptor related. Bos R; van Diest PJ; van der Groep P; Shvarts A; Greijer AE; van der Wall E Breast Cancer Res; 2004; 6(4):R450-9. PubMed ID: 15217513 [TBL] [Abstract][Full Text] [Related]
5. Expression of hypoxic-inducible factor 1alpha predicts metastasis-free survival after radiation therapy alone in stage IIIB cervical squamous cell carcinoma. Ishikawa H; Sakurai H; Hasegawa M; Mitsuhashi N; Takahashi M; Masuda N; Nakajima M; Kitamoto Y; Saitoh J; Nakano T Int J Radiat Oncol Biol Phys; 2004 Oct; 60(2):513-21. PubMed ID: 15380586 [TBL] [Abstract][Full Text] [Related]
6. Expression of hypoxia-inducible factor 1alpha in epithelial ovarian tumors: its impact on prognosis and on response to chemotherapy. Birner P; Schindl M; Obermair A; Breitenecker G; Oberhuber G Clin Cancer Res; 2001 Jun; 7(6):1661-8. PubMed ID: 11410504 [TBL] [Abstract][Full Text] [Related]
7. [Relationship between the expression of hypoxia-inducible factor-1alpha and chemotherapy response in esophageal squamous cell carcinoma]. Wu XA; Sun Y; Fan QX; Wang LX; Wang RL Zhonghua Yi Xue Za Zhi; 2007 Jul; 87(25):1783-5. PubMed ID: 17919389 [TBL] [Abstract][Full Text] [Related]
8. Hyperinducibility of hypoxia-responsive genes without p53/p21-dependent checkpoint in aggressive prostate cancer. Salnikow K; Costa M; Figg WD; Blagosklonny MV Cancer Res; 2000 Oct; 60(20):5630-4. PubMed ID: 11059752 [TBL] [Abstract][Full Text] [Related]
9. [Impact of RNA interference targeting hypoxia-inducible factor-1alpha on chemosensitivity in esophageal squamous cell carcinoma cells under hypoxia]. Wu XA; Sun Y; Fan QX; Wang LX; Wang RL; Zhang L Zhonghua Yi Xue Za Zhi; 2007 Oct; 87(37):2640-4. PubMed ID: 18162154 [TBL] [Abstract][Full Text] [Related]
10. Predictive value of p53 and 14-3-3sigma for the effect of chemoradiation therapy on esophageal squamous cell carcinoma. Okumura H; Natsugoe S; Matsumoto M; Yokomakura N; Uchikado Y; Takatori H; Ishigami S; Takao S; Aikou T J Surg Oncol; 2005 Jul; 91(1):84-9. PubMed ID: 15999354 [TBL] [Abstract][Full Text] [Related]
11. Dysregulation of hypoxia inducible factor-1alpha in head and neck squamous cell carcinoma cell lines correlates with invasive potential. Cohen NA; Lai SY; Ziober AF; Ziober BL Laryngoscope; 2004 Mar; 114(3):418-23. PubMed ID: 15091212 [TBL] [Abstract][Full Text] [Related]
12. Evaluation of hypoxia-inducible factor 1alpha overexpression as a predictor of tumour recurrence and progression in superficial urothelial bladder carcinoma. Theodoropoulos VE; Lazaris AC; Kastriotis I; Spiliadi C; Theodoropoulos GE; Tsoukala V; Patsouris E; Sofras F BJU Int; 2005 Feb; 95(3):425-31. PubMed ID: 15679808 [TBL] [Abstract][Full Text] [Related]
13. Correlation of hypoxia inducible factor-1alpha with lymphatic metastasis via vascular endothelial growth factor-C in human esophageal cancer. Katsuta M; Miyashita M; Makino H; Nomura T; Shinji S; Yamashita K; Tajiri T; Kudo M; Ishiwata T; Naito Z Exp Mol Pathol; 2005 Apr; 78(2):123-30. PubMed ID: 15713437 [TBL] [Abstract][Full Text] [Related]
14. Role of HIF-1alpha in hypoxia-mediated apoptosis, cell proliferation and tumour angiogenesis. Carmeliet P; Dor Y; Herbert JM; Fukumura D; Brusselmans K; Dewerchin M; Neeman M; Bono F; Abramovitch R; Maxwell P; Koch CJ; Ratcliffe P; Moons L; Jain RK; Collen D; Keshert E Nature; 1998 Jul; 394(6692):485-90. PubMed ID: 9697772 [TBL] [Abstract][Full Text] [Related]
15. The relation between hypoxia-inducible factor (HIF)-1alpha expression with p53 expression and outcome in surgically treated supraglottic laryngeal cancer. Cabanillas R; Rodrigo JP; Secades P; Astudillo A; Nieto CS; Chiara MD J Surg Oncol; 2009 May; 99(6):373-8. PubMed ID: 19226532 [TBL] [Abstract][Full Text] [Related]
16. Expression of the prolyl isomerase Pin1 is a useful indicator of sensitivity to chemoradiotherapy in advanced esophageal squamous cell carcinoma. Fukuchi M; Fukai Y; Sohda M; Miyazaki T; Nakajima M; Inose T; Tanaka N; Tsukada K; Kato H; Kuwano H Oncol Rep; 2009 Apr; 21(4):853-9. PubMed ID: 19287979 [TBL] [Abstract][Full Text] [Related]
17. Levels of hypoxia-inducible factor-1alpha independently predict prognosis in patients with lymph node negative breast carcinoma. Bos R; van der Groep P; Greijer AE; Shvarts A; Meijer S; Pinedo HM; Semenza GL; van Diest PJ; van der Wall E Cancer; 2003 Mar; 97(6):1573-81. PubMed ID: 12627523 [TBL] [Abstract][Full Text] [Related]
18. Clinical significance of hypoxia-inducible factor 1α, and its correlation with p53 and vascular endothelial growth factor expression in resectable esophageal squamous cell carcinoma. Shao N; Han Y; Song L; Song W J Cancer Res Ther; 2020; 16(2):269-275. PubMed ID: 32474512 [TBL] [Abstract][Full Text] [Related]
19. Overexpression of hypoxia-inducible factor HIF-1alpha predicts early relapse in breast cancer: retrospective study in a series of 745 patients. Dales JP; Garcia S; Meunier-Carpentier S; Andrac-Meyer L; Haddad O; Lavaut MN; Allasia C; Bonnier P; Charpin C Int J Cancer; 2005 Sep; 116(5):734-9. PubMed ID: 15849727 [TBL] [Abstract][Full Text] [Related]
20. [Expression of hypoxia-inducible factor-1alpha and vessel endothelial growth factor in esophageal squamous cell carcinoma and clinico-pathological significance thereof]. Yu ZT; Zhao HF; Shang XB Zhonghua Yi Xue Za Zhi; 2008 Sep; 88(35):2465-9. PubMed ID: 19080625 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]